NIH-funded research NIH-funded research

Understanding how certain proteins help cells communicate and function.

Official title: Phospholipase C Isozymes

Funded at Univ of North Carolina Chapel Hill · NIH-11057726 · Data updated 2026-11-12

This study is looking at how certain proteins help cells talk to each other and respond to signals, which could help us understand how our bodies work in both health and illness.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startMay 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$384,915
NIH project number5R35GM149299-03
Project IDNIH-11057726 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with conditions that involve disrupted cellular signaling, such as certain cancers or immune disorders.

Less likely to help

Patients with conditions unrelated to cellular signaling or those who do not have any known biochemical signaling issues may not benefit from this research.

What this research studies

This research investigates the role of phospholipase C isozymes in cellular communication and signaling. By examining how these proteins interact with various receptors on cell membranes, the study aims to uncover the fundamental principles of how cells transmit information. The approach involves detailed structural and biochemical analyses, allowing researchers to understand the specific responses of different cell types to various signals. This knowledge could lead to insights into how cellular processes are regulated in health and disease.

Why it matters

Potential benefit: If successful, this research could enhance our understanding of cellular signaling, potentially leading to new therapeutic strategies for diseases related to cell communication.

How similar studies have gone: Previous research has shown success in understanding cellular signaling mechanisms, indicating that this approach has the potential for meaningful discoveries.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Sondek, John E — Univ of North Carolina Chapel Hill
  • Study coordinator: Sondek, John E

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.